[ad_1] China’s National Pharmaceutical Group (Sinofarm) will examine the results of the third phase of an overseas clinical trial, to decide whether a double dose of its coronavirus vaccine should be accompanied by another revaccination, an official with the Chinese government said on Sunday. company. According to Reuters, regulators and …
Read More »Sinofarm is examining whether the third dose of the vaccine would create an even higher number of antibodies
